Artificial intelligence has the potential to accelerate drug discovery by generating new molecular structures, automatically designing drug candidates, and using historical data to identify treatments. Companies are using AI techniques like deep learning and generative adversarial networks to analyze vast amounts of data to propose new drug candidates. Robots are also being used in pharmaceutical laboratories and manufacturing to perform repetitive and precise tasks, allowing researchers to focus on higher-level work. Computational fluid dynamics is another tool being used to analyze and optimize pharmaceutical processes.